A Phase 3, Randomized, Double-Blind Clinical Trial to Evaluate the Efficacy and Safety of Abatacept SC With Standard Treatment Compared to Standard Treatment Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy (IIM)
收藏DataCite Commons2026-03-02 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012804/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Trial to Evaluate the Efficacy and Safety of Abatacept subcutaneous (SC) in Combination With Standard Therapy Compared to Standard Therapy Alone in Improving Disease Activity in Adults With Active Idiopathic Inflammatory Myopathy
提供机构：
Vivli
创建时间：
2026-03-02
